Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 98

    1.

    Mixed-meal tolerance test versus glucagon stimulation test for the assessment of beta-cell function in therapeutic trials in type 1 diabetes.

    Greenbaum CJ, Mandrup-Poulsen T, McGee PF, Battelino T, Haastert B, Ludvigsson J, Pozzilli P, Lachin JM, Kolb H; Type 1 Diabetes Trial Net Research Group; European C-Peptide Trial Study Group.

    Diabetes Care. 2008 Oct;31(10):1966-71. Epub 2008 Jul 15.PMID: 18628574 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Impaired beta-cell and alpha-cell function in African-American children with type 2 diabetes mellitus--"Flatbush diabetes".

    Banerji MA.

    J Pediatr Endocrinol Metab. 2002 Apr;15 Suppl 1:493-501. Review.PMID: 12017222 [PubMed - indexed for MEDLINE]Related articles

    3.

    Beta-cell response to intravenous glucagon in African-American and Hispanic children with type 2 diabetes mellitus.

    Taha DR, Castells S, Umpaichitra V, Bastian W, Banerji MA.

    J Pediatr Endocrinol Metab. 2002 Jan;15(1):59-67.PMID: 11822582 [PubMed - indexed for MEDLINE]Related articles

    4.

    Beta-cell function in relation to islet cell antibodies during the first 3 yr after clinical diagnosis of diabetes in type II diabetic patients.

    Gottsäter A, Landin-Olsson M, Fernlund P, Lernmark A, Sundkvist G.

    Diabetes Care. 1993 Jun;16(6):902-10.PMID: 8325204 [PubMed - indexed for MEDLINE]Related articles

    5.

    Effect of ingested interferon-alpha on beta-cell function in children with new-onset type 1 diabetes.

    Rother KI, Brown RJ, Morales MM, Wright E, Duan Z, Campbell C, Hardin DS, Popovic J, McEvoy RC, Harlan DM, Orlander PR, Brod SA.

    Diabetes Care. 2009 Jul;32(7):1250-5. Erratum in: Diabetes Care. 2009 Sep;32(9):1751. PMID: 19564474 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Independent measures of insulin secretion and insulin sensitivity during the same test: the glucagon-insulin tolerance test.

    Dorkhan M, Tripathy D, Malm G, Asgharian H, Tuomi T, Groop L.

    J Intern Med. 2008 Jul;264(1):62-71. Epub 2008 Feb 21.PMID: 18298489 [PubMed - indexed for MEDLINE]Related articles

    7.

    Decrement of postprandial insulin secretion determines the progressive nature of type-2 diabetes.

    Shim WS, Kim SK, Kim HJ, Kang ES, Ahn CW, Lim SK, Lee HC, Cha BS.

    Eur J Endocrinol. 2006 Oct;155(4):615-22.PMID: 16990662 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.

    Vilsbøll T, Krarup T, Sonne J, Madsbad S, Vølund A, Juul AG, Holst JJ.

    J Clin Endocrinol Metab. 2003 Jun;88(6):2706-13.PMID: 12788877 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Evaluation of beta-cell function in diabetic Taiwanese children using a 6-min glucagon test.

    Tung YC, Lee JS, Tsai WY, Hsiao PH.

    Eur J Pediatr. 2008 Jul;167(7):801-5. Epub 2007 Sep 15.PMID: 17874132 [PubMed - indexed for MEDLINE]Related articles

    10.

    Metabolic factors affecting residual beta cell function assessed by C-peptide secretion in patients with newly diagnosed type 1 diabetes.

    Picardi A, Visalli N, Lauria A, Suraci C, Buzzetti R, Merola MK, Manfrini S, Guglielmi C, Gentilucci UV, Pitocco D, Crinò A, Bizzarri C, Cappa M, Pozzilli P.

    Horm Metab Res. 2006 Oct;38(10):668-72.PMID: 17075776 [PubMed - indexed for MEDLINE]Related articles

    11.

    C-peptide response to glucagon. A test for the residual beta-cell function in diabetes mellitus.

    Faber OK, Binder C.

    Diabetes. 1977 Jul;26(7):605-10.PMID: 326604 [PubMed - indexed for MEDLINE]Related articles

    12.

    Cyclosporine in recent onset type I diabetes mellitus. Effects on islet beta cell function. Miami Cyclosporine Diabetes Study Group.

    Skyler JS, Rabinovitch A.

    J Diabetes Complications. 1992 Apr-Jun;6(2):77-88.PMID: 1611143 [PubMed - indexed for MEDLINE]Related articles

    13.

    Use of an islet cell antibody assay to identify type 1 diabetic patients with rapid decrease in C-peptide levels after clinical onset. Belgian Diabetes Registry.

    Decochez K, Keymeulen B, Somers G, Dorchy H, De Leeuw IH, Mathieu C, Rottiers R, Winnock F, ver Elst K, Weets I, Kaufman L, Pipeleers DG, Rottiers R; Belgian Diabetes Registry.

    Diabetes Care. 2000 Aug;23(8):1072-8.PMID: 10937500 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Assessment of residual insulin secretion in diabetic patients using the intravenous glucagon stimulatory test: methodological aspects and clinical applications.

    Scheen AJ, Castillo MJ, Lefèbvre PJ.

    Diabetes Metab. 1996 Dec;22(6):397-406. Review.PMID: 8985647 [PubMed - indexed for MEDLINE]Related articles

    15.

    High-dose intravenous insulin infusion versus intensive insulin treatment in newly diagnosed IDDM.

    Schnell O, Eisfelder B, Standl E, Ziegler AG.

    Diabetes. 1997 Oct;46(10):1607-11.PMID: 9313757 [PubMed - indexed for MEDLINE]Related articles

    16.

    Insulin and C-peptide levels, pancreatic beta cell function, and insulin resistance across glucose tolerance status in Thais.

    Chailurkit LO, Jongjaroenprasert W, Chanprasertyothin S, Ongphiphadhanakul B.

    J Clin Lab Anal. 2007;21(2):85-90.PMID: 17385686 [PubMed - indexed for MEDLINE]Related articles

    17.

    C-peptide and glucagon profiles in minority children with type 2 diabetes mellitus.

    Umpaichitra V, Bastian W, Taha D, Banerji MA, AvRuskin TW, Castells S.

    J Clin Endocrinol Metab. 2001 Apr;86(4):1605-9.PMID: 11297591 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Too much glucagon, too little insulin: time course of pancreatic islet dysfunction in new-onset type 1 diabetes.

    Brown RJ, Sinaii N, Rother KI.

    Diabetes Care. 2008 Jul;31(7):1403-4.PMID: 18594062 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Progressive deterioration of beta-cell function in nonobese type 2 diabetic subjects. Postprandial plasma C-peptide level is an indication of insulin dependency.

    Prando R, Odetti P, Melga P, Giusti R, Ciuchi E, Cheli V.

    Diabetes Metab. 1996 Jun;22(3):185-91.PMID: 8697306 [PubMed - indexed for MEDLINE]Related articles

    20.

    Markers of beta cell function in type 1 diabetes mellitus.

    Vendrame F, Zappaterreno A, Dotta F.

    Minerva Med. 2004 Apr;95(2):79-84. Review.PMID: 15272242 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data